Works by Jo, Young-Il


Results: 12
    1
    2
    3

    Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.

    Published in:
    Nephrology Dialysis Transplantation, 2021, v. 36, n. 2, p. 295, doi. 10.1093/ndt/gfz168
    By:
    • Lee, Yu Ho;
    • Kim, Ki Pyo;
    • Park, Sun-Hwa;
    • Kim, Dong-Jin;
    • Kim, Yang-Gyun;
    • Moon, Ju-Young;
    • Jung, Su-Woong;
    • Kim, Jin Sug;
    • Jeong, Kyung-Hwan;
    • Lee, So-Young;
    • Yang, Dong-Ho;
    • Lim, Sung-Jig;
    • Woo, Jeong-Taek;
    • Rhee, Sang Youl;
    • Chon, Suk;
    • Choi, Hoon-Young;
    • Park, Hyeong-Cheon;
    • Jo, Young-Il;
    • Yi, Joo-Hark;
    • Han, Sang-Woong
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 292, doi. 10.1111/dom.13059
    By:
    • Han, Sang Youb;
    • Yoon, Sun Ae;
    • Han, Byoung Geun;
    • Kim, Sung Gyun;
    • Jo, Young‐Il;
    • Jeong, Kyung Hwan;
    • Oh, Kook‐Hwan;
    • Park, Hyeong Cheon;
    • Park, Sun‐Hee;
    • Kang, Shin‐Wook;
    • Na, Ki‐Ryang;
    • Kang, Sun Woo;
    • Kim, Nam‐Ho;
    • Jang, Younghwan;
    • Kim, Bogyeong;
    • Shin, Seonghye;
    • Cha, Dae Ryong
    Publication type:
    Article
    11
    12